Hussam Eltoukhy

Hussam Eltoukhy practices at Barnabas Health Medical Group in West Orange, New Jersey.

Hussam Eltoukhy's NPI, 1356737324, was assigned on April 7, 2015. Hussam Eltoukhy graduated from Rutgers New Jersey Medical School in 2015. Hussam Eltoukhy holds New Jersey license 25MA10838500.

Hussam Eltoukhy's primary practice is Barnabas Health Medical Group, at 95 Old Short Hills Rd, West Orange, NJ 07052 in Essex County. The practice phone is (973) 322-4921.

Hussam Eltoukhy's primary practice is Barnabas Health Medical Group in West Orange, New Jersey. Hussam Eltoukhy is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Hussam Eltoukhy to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hussam Eltoukhy practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Hussam Eltoukhy's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Hussam Eltoukhy is licensed in New Jersey.

CMS data shows 1,342 Medicare services from Hussam Eltoukhy across 11 procedure codes in 2024, for 491 Medicare patients. Medicare paid $108,602 for them.

CMS counts 491 Medicare patients who saw Hussam Eltoukhy in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hussam Eltoukhy's median patient age at 72, with 51% women.

In 2024, Hussam Eltoukhy wrote 882 Medicare Part D claims for 147 patients. 69% of them were for generic drugs. CMS names the drug for 696 of them, across 23 drugs with 11 or more claims each, at $2,646,688 in total drug cost. In 2023, CMS named 279 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Hussam Eltoukhy for performance year 2024, reported through an alternative payment model (APM). Hussam Eltoukhy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Hussam Eltoukhy as offering telehealth.

Dmand AI links 4 papers to Hussam Eltoukhy, published from 2017 to 2023. The most frequent topics are Cell Survival and Mesenchymal Stem Cells. Hussam Eltoukhy has published most often in World J Oncol. Hussam Eltoukhy's most frequent co-authors are Doantrang T. Du, MD, Varsha Gupta, MD and Aasems Jacob, MD.

CMS Open Payments shows 114 general payments to Hussam Eltoukhy from 30 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 97% of the total. Daiichi Sankyo Inc. paid the most, $371.

Hussam Eltoukhy graduated from Rutgers New Jersey Medical School in 2015.